LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Начало・Списък с акции・Inspire Medical Systems Inc

Inspire Medical Systems Inc

Затворен

СекторЗдравеопазване

57.69 -0.98

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

56.96

Максимум

59.13

Ключови измерители
By Trading Economics
Приходи	126M 136M
Продажби	45M 269M
P/E Средно за сектора	11.92 108.767
Марж на печалбата	50.577
Служители	1,333
EBITDA	33M 50M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+57.18% upside

Дивиденти
By Dow Jones
Следващи печалби	4.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-268M 1.7B
Предишно отваряне	58.67
Предишно затваряне	57.69

Настроения в новините

By Acuity

50%

161 / 351 Класиране в Healthcare

Inspire Medical Systems Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.02.2026 г., 23:07 ч. UTC

Печалби

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24.02.2026 г., 23:01 ч. UTC

Печалби

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24.02.2026 г., 22:59 ч. UTC

Печалби

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24.02.2026 г., 22:42 ч. UTC

Печалби

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24.02.2026 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24.02.2026 г., 23:46 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24.02.2026 г., 23:36 ч. UTC

Пазарно говорене

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24.02.2026 г., 23:30 ч. UTC

Пазарно говорене

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24.02.2026 г., 23:20 ч. UTC

Пазарно говорене

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24.02.2026 г., 23:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

24.02.2026 г., 23:16 ч. UTC

Печалби

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24.02.2026 г., 23:13 ч. UTC

Печалби

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24.02.2026 г., 23:12 ч. UTC

Печалби

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24.02.2026 г., 23:10 ч. UTC

Печалби

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24.02.2026 г., 23:10 ч. UTC

Печалби

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24.02.2026 г., 23:08 ч. UTC

Печалби

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24.02.2026 г., 23:07 ч. UTC

Печалби

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24.02.2026 г., 22:52 ч. UTC

Печалби

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24.02.2026 г., 22:46 ч. UTC

Печалби

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24.02.2026 г., 22:31 ч. UTC

Придобивния, сливания и поглъщания

Warner Receives New Bid From Paramount -- 3rd Update

24.02.2026 г., 22:29 ч. UTC

Печалби

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24.02.2026 г., 22:28 ч. UTC

Печалби

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24.02.2026 г., 22:27 ч. UTC

Печалби

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24.02.2026 г., 22:27 ч. UTC

Печалби

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24.02.2026 г., 22:25 ч. UTC

Печалби

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24.02.2026 г., 22:24 ч. UTC

Печалби

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24.02.2026 г., 22:23 ч. UTC

Печалби

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24.02.2026 г., 22:22 ч. UTC

Печалби

Woolworths Interim Dividend 45 Australian Cents/Share

24.02.2026 г., 22:22 ч. UTC

Печалби

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24.02.2026 г., 22:21 ч. UTC

Печалби

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Сравнение с други в отрасъла

Ценова промяна

Inspire Medical Systems Inc Прогноза

Ценова цел

By TipRanks

57.18% нагоре

12-месечна прогноза

Среден 91.62 USD 57.18%

Висок 175 USD

Нисък 60 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Inspire Medical Systems Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

18 ratings

Купи

Задържане

Продай

Според 18 анализатори, дали борсови рейтинги на Inspire Medical Systems Inc през последните 3 месеца.

Настроение

By Acuity

161 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.